BMW / WATSON LABORATORIES INC. / Enzo Biochem Inc. / Hitachi / Apotex Inc. / WATSON PHARMACEUTICALS INC. / N. Am. Inc. / CEPHALON / INC. AND CIMA LABS / INC. / Watson Pharma Inc. / Calgene Inc. / Wilmer Cutler Pickering Hale and Dorr LLP / MagSil Corp. / ALZA Corp. / Cephalon Inc. / STRONSKI / Crowell & Moring / LLP / /
Event
Reorganization / FDA Phase / /
Facility
United States District Court / /
IndustryTerm
pharmaceutical agent / drug product / Carbon dioxide gas / pharmaceutical agents / chemical reaction / food acids / treatment of breakthrough cancer / pharmaceutical ingredients / distributable pharmaceutical agent / /
MedicalCondition
breakthrough cancer pain / /
Organization
United States District Court for the District of Delaware / United States Court of Appeals / US Federal Reserve / FDA / /
Person
MARK C. FLEMING / Sue L. Robinson / CAROLYN JACOBS CHACHKIN / JACOB S. OYLE / WILLIAM F. LEE / Rajentra K. Khankari / Sathasivan Indiran Pather / D. SUZUKI / Joseph R. Robinson / WILLIAM G. MCELWAIN / John Hontz / JACOB Z. ZAMBRZYCKI / Jonathan D. Eichman / Bryson / /